| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |